IDEX Corporation filings document formal disclosures for an NYSE-listed engineered products company with common stock trading under IEX. Recent 8-K reports furnish quarterly and annual operating results, press-release exhibits, share repurchase authorization, capital-return activity, and executive officer changes.
The company’s proxy and annual meeting filings cover board elections, advisory executive compensation votes, auditor ratification, and related governance disclosures. Its filings also identify registered common stock, Inline XBRL cover-page data, exhibit filings, and material-event reporting tied to financial condition, leadership, shareholder votes, and capital allocation.
BUTHMAN MARK A reported acquisition or exercise transactions in this Form 4 filing.
IDEX CORP director Mark A. Buthman received an equity award in the form of restricted stock units. On May 6, 2026 he was granted 805 RSUs, each representing a contingent right to receive one share of IDEX common stock.
The RSUs vest in full on the earlier of May 6, 2027 and the date of IDEX’s next annual stockholders meeting, if that meeting is at least 50 weeks after the prior year’s meeting, and only if he remains in continuous service through the vesting date. Following this grant, he directly owns 10,025 shares of common stock.
Beck Mark A reported acquisition or exercise transactions in this Form 4 filing.
IDEX CORP director Mark A. Beck received an equity award in the form of 805 shares of common stock on May 6, 2026, reported at a price of $0.00 per share as a grant.
The award is structured as restricted stock units, each representing one share of common stock, and will vest in full on the earlier of May 6, 2027, or the date of the company’s next annual stockholders meeting if that meeting occurs at least 50 weeks after the prior year’s meeting, subject to his continued service. Following this grant, Beck directly holds 7,755 shares of IDEX common stock.
IDEX Corporation reported the results of its annual stockholder meeting held on May 6, 2026. Stockholders elected four Class I directors—Mark A. Beck, Carl R. Christenson, Katrina L. Helmkamp and Alejandro Quiroz Centeno—to three-year terms ending at the 2029 annual meeting.
Stockholders also approved, on an advisory basis, the compensation of the company’s named executive officers and ratified the appointment of Deloitte & Touche LLP as IDEX’s independent registered public accounting firm for 2026.
IDEX Corp ownership update: Vanguard Capital Management reports beneficial ownership of 5,588,265 shares of common stock, representing 7.53% of the class as of 03/31/2026. The filer discloses sole dispositive power over 5,588,265 shares and sole voting power over 733,569 shares.
The Schedule 13G filing lists Vanguard Capital Management and affiliated business divisions as the reporting entity and states the holdings include securities managed for Vanguard funds and client accounts. Signature by Head of Global Fund Administration dated 04/30/2026.
IDEX Corporation reported solid first-quarter 2026 growth. Net sales rose to $886.9 million from $814.3 million, helped by 5% organic growth, favorable currency and contributions from acquisitions. Net income attributable to IDEX increased to $120.0 million from $95.5 million, with diluted EPS up to $1.61 from $1.26.
Adjusted diluted EPS reached $2.00, up from $1.75, reflecting higher volumes in advantaged markets such as data centers, semiconductors, and space and defense within Health & Science Technologies. Gross margin eased slightly to 44.9% from 45.3% as unfavorable mix and price/cost pressure offset productivity gains and volume leverage.
IDEX generated $103.7 million of operating cash flow and $86.0 million of free cash flow, while investing $17.7 million in capital expenditures. The company returned cash to shareholders through $75.6 million of share repurchases and $52.8 million of dividends. The balance sheet showed $586.2 million of cash, total borrowings of $1.88 billion, and ample liquidity with $517.2 million available under its $800 million revolving facility.
IDEX Corp ownership disclosure: Vanguard Portfolio Management reports beneficial ownership of 3,777,844 shares of IDEX common stock, representing 5.09% of the class. The filing states this position reflects holdings across Vanguard Portfolio Management LLC and affiliated business divisions, per SEC Release No. 34-39538.
IDEX Corporation reported strong first-quarter 2026 results, with net sales of $886.9 million, up 9% from a year earlier, driven by 5% organic growth and contributions from acquisitions and foreign currency. Net income attributable to IDEX rose to $120.0 million, lifting diluted EPS from $1.26 to $1.61, while adjusted diluted EPS increased 14% to $2.00.
Orders reached a record $988.3 million, up 13% reported and 10% organically, indicating solid demand, especially in the Health & Science Technologies segment, which grew sales 17%. Adjusted EBITDA improved to $230.4 million with a 26.0% margin. Operating cash flow was $103.7 million and free cash flow was $86.0 million, slightly below the prior year as higher earnings were offset by working capital and higher capital spending.
The company returned capital through $76.3 million of share repurchases and $52.8 million of dividends. Based on current momentum, IDEX raised its full-year 2026 outlook, now projecting organic sales growth of 3–4% and adjusted diluted EPS of $8.35–$8.55, and guided second-quarter organic sales growth of 3–4% with adjusted diluted EPS of $2.07–$2.12.
IDEX Corp Schedule 13G/A: The Vanguard Group states it beneficially owns 0 shares of IDEX Corp common stock and reports 0% ownership. The filing explains an internal realignment effective January 12, 2026 that caused certain Vanguard subsidiaries/divisions to report separately under SEC Release No. 34-39538. The filing is signed by Ashley Grim on 03/27/2026.
IDEX Corporation is soliciting proxies for its 2026 virtual annual stockholders meeting on May 6, 2026 at 9:00 a.m. Central Time. Holders of common stock as of March 12, 2026 can attend and vote online using a 16-digit control number.
Stockholders will vote on electing four Class I directors for three-year terms, an advisory approval of named executive officer compensation, and ratification of Deloitte & Touche LLP as independent auditor for 2026. The Board recommends voting FOR all three proposals.
The proxy details a 10‑member, largely independent Board, its committee structure, governance practices, risk and cybersecurity oversight, and sustainability program. It also explains director compensation, stock ownership guidelines, and the executive compensation framework, including incentive plans, peer benchmarking, and use of an independent compensation consultant.